Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Syncytial Virus Infections | 7 | 2011 | 324 | 1.340 |
Why?
|
Respiratory Syncytial Viruses | 5 | 2011 | 164 | 1.150 |
Why?
|
Babesia microti | 1 | 2019 | 31 | 0.680 |
Why?
|
Cellulitis | 6 | 2023 | 206 | 0.670 |
Why?
|
Necrobiotic Disorders | 2 | 2015 | 5 | 0.660 |
Why?
|
Babesiosis | 1 | 2019 | 90 | 0.640 |
Why?
|
Blood | 1 | 2019 | 598 | 0.570 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 290 | 0.550 |
Why?
|
Lidocaine | 2 | 2014 | 542 | 0.490 |
Why?
|
Viral Load | 4 | 2011 | 3292 | 0.490 |
Why?
|
Vancomycin | 1 | 2017 | 500 | 0.470 |
Why?
|
Cannabis | 1 | 2020 | 432 | 0.460 |
Why?
|
Communicable Diseases | 1 | 2020 | 878 | 0.400 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 687 | 0.390 |
Why?
|
Drug Monitoring | 1 | 2017 | 956 | 0.380 |
Why?
|
Aspergillus flavus | 2 | 2013 | 14 | 0.380 |
Why?
|
Anesthetics, Local | 2 | 2014 | 984 | 0.380 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 32 | 0.360 |
Why?
|
Fractures, Compression | 1 | 2011 | 134 | 0.340 |
Why?
|
Staphylococcal Infections | 3 | 2022 | 1398 | 0.330 |
Why?
|
Hypercalcemia | 1 | 2011 | 405 | 0.320 |
Why?
|
Guideline Adherence | 1 | 2017 | 2266 | 0.280 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.280 |
Why?
|
Lymphopenia | 1 | 2008 | 285 | 0.260 |
Why?
|
Fungemia | 1 | 2005 | 53 | 0.260 |
Why?
|
Antigens, Fungal | 1 | 2005 | 70 | 0.260 |
Why?
|
Crohn Disease | 2 | 2015 | 2301 | 0.260 |
Why?
|
Mannans | 1 | 2005 | 63 | 0.260 |
Why?
|
Immunocompromised Host | 2 | 2008 | 847 | 0.260 |
Why?
|
Bacillus cereus | 1 | 2004 | 35 | 0.250 |
Why?
|
Opportunistic Infections | 1 | 2008 | 389 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2011 | 1515 | 0.250 |
Why?
|
Spinal Fractures | 1 | 2011 | 698 | 0.240 |
Why?
|
Crying | 1 | 2024 | 36 | 0.240 |
Why?
|
Infant | 12 | 2024 | 35070 | 0.230 |
Why?
|
Anti-Bacterial Agents | 6 | 2022 | 7153 | 0.230 |
Why?
|
Education, Medical | 1 | 2015 | 1717 | 0.230 |
Why?
|
Aspergillosis | 1 | 2005 | 235 | 0.230 |
Why?
|
Pandemics | 2 | 2020 | 8328 | 0.230 |
Why?
|
Fungi | 1 | 2006 | 327 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2853 | 0.220 |
Why?
|
Mycoses | 1 | 2006 | 376 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Respiratory Tract Infections | 1 | 2009 | 959 | 0.210 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2004 | 137 | 0.210 |
Why?
|
Quality Improvement | 1 | 2017 | 3738 | 0.200 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2004 | 341 | 0.200 |
Why?
|
Lung | 3 | 2015 | 9826 | 0.200 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3839 | 0.200 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1844 | 0.200 |
Why?
|
Communication | 1 | 2015 | 3728 | 0.200 |
Why?
|
Muscle Weakness | 1 | 2024 | 414 | 0.190 |
Why?
|
Respiratory Tract Diseases | 1 | 2006 | 722 | 0.190 |
Why?
|
Staphylococcus | 1 | 2020 | 155 | 0.190 |
Why?
|
Pediatrics | 1 | 2015 | 3462 | 0.180 |
Why?
|
Streptococcus | 1 | 2020 | 197 | 0.180 |
Why?
|
Bacteremia | 2 | 2020 | 962 | 0.180 |
Why?
|
Mastoiditis | 1 | 2020 | 34 | 0.180 |
Why?
|
Clinical Competence | 1 | 2015 | 4681 | 0.180 |
Why?
|
Tuberculosis, Cardiovascular | 1 | 1999 | 9 | 0.170 |
Why?
|
Tuberculoma | 1 | 1999 | 14 | 0.170 |
Why?
|
New Hampshire | 1 | 2019 | 172 | 0.170 |
Why?
|
Severity of Illness Index | 4 | 2011 | 15530 | 0.170 |
Why?
|
Hospitalization | 4 | 2021 | 10232 | 0.170 |
Why?
|
Renal Insufficiency | 1 | 2005 | 802 | 0.170 |
Why?
|
Beverages | 1 | 2004 | 820 | 0.170 |
Why?
|
Splenomegaly | 1 | 2019 | 190 | 0.170 |
Why?
|
Child, Preschool | 9 | 2020 | 40955 | 0.170 |
Why?
|
Inpatients | 4 | 2022 | 2495 | 0.150 |
Why?
|
Child | 17 | 2023 | 77478 | 0.150 |
Why?
|
Otitis Media | 1 | 2020 | 277 | 0.150 |
Why?
|
Massachusetts | 2 | 2020 | 8662 | 0.150 |
Why?
|
Physicians | 1 | 2015 | 4554 | 0.150 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2023 | 778 | 0.140 |
Why?
|
Fever | 3 | 2019 | 1612 | 0.140 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2763 | 0.140 |
Why?
|
Hospitals, General | 1 | 2020 | 749 | 0.140 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1999 | 654 | 0.130 |
Why?
|
Internship and Residency | 1 | 2015 | 5774 | 0.130 |
Why?
|
Humans | 35 | 2024 | 742088 | 0.130 |
Why?
|
Severe Combined Immunodeficiency | 2 | 2008 | 221 | 0.120 |
Why?
|
Skin Diseases | 1 | 2022 | 1065 | 0.120 |
Why?
|
Bordetella pertussis | 1 | 2013 | 43 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.110 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 664 | 0.110 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2013 | 61 | 0.110 |
Why?
|
Bacterial Load | 1 | 2013 | 153 | 0.110 |
Why?
|
Whooping Cough | 1 | 2013 | 82 | 0.110 |
Why?
|
Anemia | 2 | 2019 | 1499 | 0.110 |
Why?
|
Nasal Lavage Fluid | 1 | 2011 | 16 | 0.100 |
Why?
|
Groin | 2 | 2022 | 102 | 0.100 |
Why?
|
Buttocks | 2 | 2022 | 110 | 0.100 |
Why?
|
Aspergillus fumigatus | 1 | 2013 | 150 | 0.100 |
Why?
|
Needles | 1 | 2014 | 448 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1171 | 0.100 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 1760 | 0.100 |
Why?
|
Length of Stay | 3 | 2023 | 6294 | 0.100 |
Why?
|
Male | 18 | 2024 | 349538 | 0.090 |
Why?
|
Female | 16 | 2020 | 379592 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 15494 | 0.090 |
Why?
|
Critical Care | 2 | 2014 | 2640 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 402 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 569 | 0.090 |
Why?
|
Dexmedetomidine | 1 | 2014 | 315 | 0.090 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2271 | 0.090 |
Why?
|
Bradycardia | 1 | 2011 | 305 | 0.080 |
Why?
|
Abscess | 2 | 2022 | 607 | 0.080 |
Why?
|
Sequence Analysis, Protein | 1 | 2009 | 257 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3062 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2016 | 1413 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.070 |
Why?
|
Neoplasms | 2 | 2008 | 21596 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2014 | 979 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.070 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 417 | 0.070 |
Why?
|
Back Pain | 1 | 2011 | 545 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10163 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2023 | 77098 | 0.070 |
Why?
|
Equipment Design | 1 | 2014 | 3582 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1158 | 0.070 |
Why?
|
Filtration | 1 | 2006 | 234 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2006 | 102 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2016 | 12958 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3465 | 0.060 |
Why?
|
Viral Fusion Proteins | 1 | 2004 | 95 | 0.060 |
Why?
|
Galactose | 1 | 2005 | 306 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 53187 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1255 | 0.060 |
Why?
|
Radiography | 2 | 2013 | 7010 | 0.060 |
Why?
|
Heart Rate | 1 | 2014 | 4091 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1199 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 85649 | 0.050 |
Why?
|
Gene Frequency | 1 | 2009 | 3587 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2004 | 792 | 0.050 |
Why?
|
Specimen Handling | 1 | 2006 | 692 | 0.050 |
Why?
|
Critical Illness | 1 | 2014 | 2665 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7645 | 0.050 |
Why?
|
Logistic Models | 2 | 2013 | 13403 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2004 | 657 | 0.040 |
Why?
|
Ultrasonography | 3 | 2020 | 5978 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2020 | 276 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2009 | 2566 | 0.040 |
Why?
|
Blood Pressure | 1 | 2014 | 8541 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14720 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
Nose | 1 | 2021 | 509 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.040 |
Why?
|
Hepatitis B | 1 | 2003 | 695 | 0.040 |
Why?
|
Pallor | 1 | 2016 | 5 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2005 | 1780 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12946 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2041 | 0.030 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2014 | 153 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13814 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 3497 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 324 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4147 | 0.020 |
Why?
|
Age Factors | 1 | 2008 | 18355 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1999 | 1319 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 344 | 0.020 |
Why?
|
Chronic Disease | 1 | 2005 | 9144 | 0.020 |
Why?
|
Abdomen | 1 | 2016 | 1107 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40054 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35342 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2016 | 1059 | 0.020 |
Why?
|
Cough | 1 | 2013 | 555 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2023 | 25575 | 0.020 |
Why?
|
Celiac Disease | 1 | 2016 | 785 | 0.020 |
Why?
|
United States | 1 | 2015 | 69693 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2004 | 21719 | 0.020 |
Why?
|
Antiviral Agents | 1 | 1999 | 2978 | 0.020 |
Why?
|
Echocardiography | 1 | 1999 | 5097 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4929 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2013 | 0.020 |
Why?
|
Chest Pain | 1 | 2013 | 1113 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20086 | 0.020 |
Why?
|
Dyspnea | 1 | 2013 | 1298 | 0.020 |
Why?
|
Virology | 1 | 2005 | 77 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15194 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3766 | 0.020 |
Why?
|
Brain | 1 | 2011 | 26343 | 0.010 |
Why?
|
Risk Factors | 2 | 2008 | 72145 | 0.010 |
Why?
|
Lung Diseases | 1 | 2013 | 1884 | 0.010 |
Why?
|
Lebanon | 1 | 2003 | 227 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2003 | 402 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2410 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8297 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2892 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6259 | 0.010 |
Why?
|
RNA, Viral | 1 | 2005 | 2899 | 0.010 |
Why?
|
Adult | 2 | 2014 | 213712 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12797 | 0.010 |
Why?
|
Middle Aged | 2 | 2014 | 213127 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29010 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7721 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 62966 | 0.000 |
Why?
|
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_